These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22253595)

  • 21. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
    Liang Y; Ganem D
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8490-5. PubMed ID: 12832621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
    Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway.
    Wang SE; Wu FY; Chen H; Shamay M; Zheng Q; Hayward GS
    J Virol; 2004 Apr; 78(8):4248-67. PubMed ID: 15047839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
    Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
    J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
    Lan K; Kuppers DA; Verma SC; Robertson ES
    J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV.
    Naik NG; Nguyen TH; Roberts L; Fischer LT; Glickman K; Golas G; Papp B; Toth Z
    PLoS Pathog; 2020 Jan; 16(1):e1008268. PubMed ID: 31923286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 modulate the Toll-like receptor-induced proinflammatory cytokine response.
    Bussey KA; Reimer E; Todt H; Denker B; Gallo A; Konrad A; Ottinger M; Adler H; Stürzl M; Brune W; Brinkmann MM
    J Virol; 2014 Aug; 88(16):9245-59. PubMed ID: 24899179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carboxyl-terminal amino acids 1052 to 1082 of the latency-associated nuclear antigen (LANA) interact with RBP-Jκ and are responsible for LANA-mediated RTA repression.
    Jin Y; He Z; Liang D; Zhang Q; Zhang H; Deng Q; Robertson ES; Lan K
    J Virol; 2012 May; 86(9):4956-69. PubMed ID: 22379075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway.
    Lu F; Stedman W; Yousef M; Renne R; Lieberman PM
    J Virol; 2010 Mar; 84(6):2697-706. PubMed ID: 20071580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Murine Gammaherpesvirus 68 Expressing Kaposi Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen (LANA) Reveals both Functional Conservation and Divergence in LANA Homologs.
    Gupta A; Oldenburg DG; Salinas E; White DW; Forrest JC
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28747501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
    Purushothaman P; Thakker S; Verma SC
    J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive and negative regulation in the promoter of the ORF46 gene of Kaposi's sarcoma-associated herpesvirus.
    Wang SS; Chang PJ; Chen LW; Chen LY; Hung CH; Liou JY; Yen JB
    Virus Res; 2012 May; 165(2):157-69. PubMed ID: 22366521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cooperation between viral interferon regulatory factor 4 and RTA to activate a subset of Kaposi's sarcoma-associated herpesvirus lytic promoters.
    Xi X; Persson LM; O'Brien MW; Mohr I; Wilson AC
    J Virol; 2012 Jan; 86(2):1021-33. PubMed ID: 22090118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sirtuin 6 Attenuates Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Suppressing Ori-Lyt Activity and Expression of RTA.
    Hu M; Armstrong N; Seto E; Li W; Zhu F; Wang PC; Tang Q
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP.
    Wang SE; Wu FY; Fujimuro M; Zong J; Hayward SD; Hayward GS
    J Virol; 2003 Jan; 77(1):600-23. PubMed ID: 12477864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide identification of binding sites for Kaposi's sarcoma-associated herpesvirus lytic switch protein, RTA.
    Chen J; Ye F; Xie J; Kuhne K; Gao SJ
    Virology; 2009 Apr; 386(2):290-302. PubMed ID: 19233445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BET-Inhibitors Disrupt Rad21-Dependent Conformational Control of KSHV Latency.
    Chen HS; De Leo A; Wang Z; Kerekovic A; Hills R; Lieberman PM
    PLoS Pathog; 2017 Jan; 13(1):e1006100. PubMed ID: 28107481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus).
    Deng H; Song MJ; Chu JT; Sun R
    J Virol; 2002 Aug; 76(16):8252-64. PubMed ID: 12134031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An alternative Kaposi's sarcoma-associated herpesvirus replication program triggered by host cell apoptosis.
    Prasad A; Lu M; Lukac DM; Zeichner SL
    J Virol; 2012 Apr; 86(8):4404-19. PubMed ID: 22345480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latency.
    Hopcraft SE; Pattenden SG; James LI; Frye S; Dittmer DP; Damania B
    PLoS Pathog; 2018 Sep; 14(9):e1007267. PubMed ID: 30212584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.